We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

84 hedge funds and large institutions have $455M invested in Trillium Therapeutics Inc. in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more call options, than puts

Call options by funds: $9.19M | Put options by funds: $3.35M

173% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 11

86% more capital invested

Capital invested by funds: $244M → $455M (+$211M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

29% more funds holding

Funds holding: 65 → 84 (+19)

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

Holders
84
Holders Change
+19
Holders Change %
+29.23%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
30
Increased
24
Reduced
21
Closed
11
Calls
$9.19M
Puts
$3.35M
Net Calls
+$5.84M
Net Calls Change
+$4.59M

Top Buyers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
+$15.8M
2
PHS
PFM Health Sciences
California
+$5.29M
3
GTC
Ghost Tree Capital
New York
+$4.33M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$3.17M
5
O
OrbiMed
New York
+$2.54M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$15.2M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$9.55M
3
VC
Vivo Capital
California
-$8.3M
4
Millennium Management
Millennium Management
New York
-$6.77M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.8M +$162K +26,200 +8%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.46M +$1.2M +193,430 +174%
PHP
28
Parkman Healthcare Partners
Connecticut
$2.43M -$773K -125,000 -29%
DMK
29
David M. Knott
$2.14M +$790K +127,725 +94%
William Blair & Company
30
William Blair & Company
Illinois
$1.9M +$1.45M +234,555 New
FIA
31
FNY Investment Advisers
New York
$1.75M +$817K +132,000 +155%
Goldman Sachs
32
Goldman Sachs
New York
$1.63M +$552K +89,182 +79%
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$1.51M -$5.23M -845,903 -82%
VIA
34
Vident Investment Advisory
Georgia
$1.43M +$1.1M +177,100 New
Morgan Stanley
35
Morgan Stanley
New York
$1.31M -$169K -27,381 -14%
LPL Financial
36
LPL Financial
California
$1.28M +$715K +115,620 +272%
Bank of America
37
Bank of America
North Carolina
$1.07M -$269K -43,542 -25%
ECM
38
ExodusPoint Capital Management
New York
$1.02M +$562K +90,800 +259%
PA
39
Perceptive Advisors
New York
$928K +$709K +114,674 New
CIP
40
Chartwell Investment Partners
Pennsylvania
$817K +$625K +100,992 New
PVI
41
Pura Vida Investments
New York
$799K +$14.2K +2,300 +2%
SCM
42
Sio Capital Management
New York
$702K -$2.05M -330,820 -79%
CSS
43
Cubist Systematic Strategies
Connecticut
$638K +$449K +72,590 +1,151%
TD Asset Management
44
TD Asset Management
Ontario, Canada
$617K +$474K +76,575 New
Two Sigma Investments
45
Two Sigma Investments
New York
$574K +$439K +70,900 New
VF
46
Virtu Financial
New York
$524K +$400K +64,711 New
RIA
47
Realta Investment Advisors
Delaware
$459K +$86.1K +13,925 +33%
HS
48
HighVista Strategies
Massachusetts
$449K +$344K +55,556 New
QSS
49
Quantitative Systematic Strategies
Florida
$411K +$202K +32,674 +180%
FAM
50
Fred Alger Management
New York
$405K +$61.9K +10,000 +25%
1
2
3 4

TRIL Hedge Fund Activity: Q2 2020 in Review

84 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q2 2020, worth a combined $455M — up 86% from $244M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new TRIL positions and 11 closed out — a net gain of 19 holders — while 24 added to existing stakes and 21 trimmed.

The largest buyer was Eventide Asset Management, opening a new position worth an estimated $15.8M. The largest seller was Deutsche Bank, cutting an estimated $15.2M.

  • 84 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q2 2020, up from 65 in Q1 2020.
  • Funds reported $455M of Trillium Therapeutics Inc. stock for Q2 2020, up 86% quarter-over-quarter.
  • 30 funds opened new Trillium Therapeutics Inc. positions in Q2 2020 and 11 closed out, a net change of +19 holders.
  • The largest Trillium Therapeutics Inc. buyer in Q2 2020 was Eventide Asset Management, an estimated $15.8M added.
  • The largest Trillium Therapeutics Inc. seller in Q2 2020 was Deutsche Bank, an estimated $15.2M sold.

Based on aggregated 13F filings for Q2 2020.